Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06017297 |
|---|---|
| Brief Title: | Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma (ESR-22-21719) |
| First Submitted : | August 24, 2023 |
| First Submitted that Met QC Criteria : | August 24, 2023 |
| First Posted : | August 30, 2023 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |